THANK YOU FOR SUBSCRIBING
Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
These Terms of Use govern your access to and use of Pharma Tech Outlook Magazine and its related digital services. By accessing or using these services, you agree to these Terms. If you do not agree, please discontinue use.
Pharma Tech Outlook grants you a limited, non-exclusive and revocable right to access and use its content for personal or legitimate business-information purposes. You may not use the website or its services in a manner that violates applicable law, interferes with their operation or infringes the rights of Pharma Tech Outlook or any third party.
Automated access, systematic extraction or collection of content may not be conducted in a manner that disrupts the website, circumvents access controls or violates applicable intellectual property rights.
Unless otherwise indicated, the articles, interviews, reports, magazine content, graphics, photographs, videos, logos, rankings, awards, website design and other materials made available by Pharma Tech Outlook are owned by or licensed to Pharma Tech Outlook and are protected by applicable intellectual property laws.
You may view or print reasonable portions of the content for personal, non-commercial reference. No content may be copied, reproduced, republished, distributed, modified, sold, licensed or commercially exploited without prior written permission from Pharma Tech Outlook or the applicable rights holder.
Company names, product names, logos and trademarks appearing in Pharma Tech Outlook may belong to their respective owners.
Content published by Pharma Tech Outlook is provided for general informational and editorial purposes. Articles, interviews and other materials may contain opinions or information provided by pharmaceutical professionals, executives, contributors or third parties. Such content does not necessarily represent the views of Pharma Tech Outlook.
Information concerning pharmaceutical research, drug development, manufacturing technology, laboratory systems, commercial practices or related matters should not be considered medical, scientific, regulatory, legal, financial or investment advice. Readers should obtain appropriate professional guidance before making decisions based on published information.
If you submit comments, articles, feedback, images or other material to Pharma Tech Outlook, you represent that you have the necessary rights to provide that material and that its use will not violate the rights of another party.
Unless otherwise agreed in writing, you grant Pharma Tech Outlook a non-exclusive, worldwide and royalty-free right to use, reproduce, edit and publish submitted material in connection with its publishing activities.
Pharma Tech Outlook may provide links to websites or services operated by third parties. It does not control those services and is not responsible for their content, availability, security or practices. Accessing third-party websites is at your own discretion.
Pharma Tech Outlook and its content are provided on an “as is” and “as available” basis. Pharma Tech Outlook does not guarantee that all content will be complete, current, uninterrupted or free from errors.
To the fullest extent permitted by applicable law, Pharma Tech Outlook will not be liable for losses or damages arising from your use of, inability to use or reliance on its website, services or content.
If you believe material published by Pharma Tech Outlook infringes your copyright or other intellectual property rights, please notify Pharma Tech Outlook with sufficient information to identify the material and the basis of your claim.
Pharma Tech Outlook may modify these Terms from time to time. Updated Terms become effective when published. Continued use of Pharma Tech Outlook Magazine and its related digital services after an update constitutes acceptance of the revised Terms.
